Merck to lower prices on some drugs, but not its blockbusters
The move follows recent announcements by Pfizer and Novartis that they would freeze price increases for the rest of the year, as the industry confronts sustained criticism from President Donald Trump, lawmakers and the public over the rising cost of prescriptions.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Katie Thomas Source Type: news
More News: American Health | Health Management | Legislation | Merck | Pfizer | Pharmaceuticals | Trump | USA Health